爱尔康
ALC74.260USD
+0.660+0.90%
收盘 10/30, 16:00（美东）报价延迟15分钟
36.73B总市值
34.23市盈率 TTM
关于 爱尔康 公司
爱尔康 是一家总部位于瑞士的眼科护理公司。该公司研究、开发、制造、分销和销售两大核心业务领域的全套眼科护理产品：外科和视力护理。该公司的外科业务专注于白内障手术、玻璃体视网膜手术、屈光激光手术和青光眼手术的眼科产品。外科产品组合包括这些手术所需的植入物、耗材和手术设备，并支持眼科医生的端到端需求。该公司的视力护理业务包括日抛型、可重复使用型和增色型隐形眼镜以及一系列眼部健康产品，包括用于干眼症、眼部过敏、青光眼和隐形眼镜护理的产品，以及眼部维生素和红肿缓解剂。该公司在 60 个国家开展业务，为 140 多个国家的消费者和患者提供服务。
爱尔康简介
公司代码ALC
公司名称Alcon AG
上市日期Apr 09, 2019
CEOMr. David J. Endicott
员工数量25599
证券类型Ordinary Share
年结日Apr 09
公司地址Rue Louis d'Affry 6
城市FRIBOURG
上市交易所SIX Swiss Exchange
国家Switzerland
邮编1700
电话41589113800
网址https://www.alcon.ch/
公司代码ALC
上市日期Apr 09, 2019
CEOMr. David J. Endicott
爱尔康公司高管
名称
名称/职务
职务
持股
持股变动
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Mr. Scott Harlan Maw
Mr. Scott Harlan Maw
Independent Director
Independent Director
17.26K
+14.57%
Ms. Ines Poeschel
Ms. Ines Poeschel
Independent Director
Independent Director
12.08K
+15.09%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
10.94K
+13.26%
Ms. Deborah Di Sanzo
Ms. Deborah Di Sanzo
Director
Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
业务USD
名称
营收
占比
Consumables
777.00M
30.15%
Contact lenses
692.00M
26.85%
Implantables
456.00M
17.69%
Ocular health
430.00M
16.69%
Equipment/other
222.00M
8.61%
Sales to Novartis Group
19.00M
0.74%
地区USD
名称
营收
占比
International
1.42B
54.99%
United States
1.16B
45.01%
业务
地区
业务USD
名称
营收
占比
Consumables
777.00M
30.15%
Contact lenses
692.00M
26.85%
Implantables
456.00M
17.69%
Ocular health
430.00M
16.69%
Equipment/other
222.00M
8.61%
Sales to Novartis Group
19.00M
0.74%
股东统计
更新时间: 8月15日 周五
更新时间: 8月15日 周五
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.13%
Aristotle Capital Management, LLC
2.41%
UBS Fund Management (Switzerland) AG
2.29%
Norges Bank Investment Management (NBIM)
2.27%
其他
83.96%
持股股东
持股股东
占比
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.13%
Aristotle Capital Management, LLC
2.41%
UBS Fund Management (Switzerland) AG
2.29%
Norges Bank Investment Management (NBIM)
2.27%
其他
83.96%
股东类型
持股股东
占比
Investment Advisor
32.41%
Investment Advisor/Hedge Fund
25.40%
Bank and Trust
4.41%
Sovereign Wealth Fund
2.35%
Hedge Fund
2.18%
Pension Fund
1.55%
Research Firm
1.45%
Individual Investor
0.13%
Insurance Company
0.09%
其他
30.03%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
1606
351.83M
70.41%
-6.16M
2025Q2
1631
340.08M
68.06%
-38.93M
2025Q1
1659
342.42M
68.52%
-42.21M
2024Q4
1636
370.45M
74.13%
+31.24M
2024Q3
1624
333.39M
66.72%
-2.12M
2024Q2
1594
337.16M
67.47%
-33.61M
2024Q1
1583
337.34M
67.51%
+4.25M
2023Q4
1598
326.79M
65.39%
-10.87M
2023Q3
1582
325.37M
65.11%
-21.48M
2023Q2
1575
329.22M
65.88%
-15.79M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Advisors (UK) Limited
24.68M
4.94%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
20.64M
4.13%
+781.14K
+3.93%
Jun 30, 2025
Aristotle Capital Management, LLC
12.04M
2.41%
-191.15K
-1.56%
Jun 30, 2025
UBS Fund Management (Switzerland) AG
11.47M
2.29%
-68.71K
-0.60%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
11.35M
2.27%
-1.28M
-10.12%
Jun 30, 2025
Fidelity Management & Research Company LLC
10.21M
2.04%
-4.82M
-32.06%
Jun 30, 2025
Zürcher Kantonalbank (Asset Management)
9.14M
1.83%
+628.34K
+7.38%
Jun 30, 2025
AKO Capital LLP
7.71M
1.54%
+597.84K
+8.40%
Jun 30, 2025
Harding Loevner LP
7.01M
1.4%
-117.33K
-1.65%
Jun 30, 2025
T. Rowe Price Associates, Inc.
6.98M
1.4%
+2.06M
+41.82%
Jun 30, 2025
查看更多
持股ETF
更新时间: 10月6日 周一
更新时间: 10月6日 周一
机构名称
占比
Franklin FTSE Switzerland ETF
2.47%
Global X Aging Population ETF
2.43%
iShares MSCI Switzerland ETF
2.3%
First Trust Indxx Medical Devices ETF
1.66%
Running Oak Efficient Growth ETF
1.64%
Global X S&P Catholic Values Developed ex-US ETF
1.04%
First Trust Switzerland Alphadex Fund
0.72%
iShares Global Healthcare ETF
0.56%
Wahed Dow Jones Islamic World ETF
0.48%
iShares ESG Advanced MSCI EAFE ETF
0.47%
查看更多
Franklin FTSE Switzerland ETF
占比2.47%
Global X Aging Population ETF
占比2.43%
iShares MSCI Switzerland ETF
占比2.3%
First Trust Indxx Medical Devices ETF
占比1.66%
Running Oak Efficient Growth ETF
占比1.64%
Global X S&P Catholic Values Developed ex-US ETF
占比1.04%
First Trust Switzerland Alphadex Fund
占比0.72%
iShares Global Healthcare ETF
占比0.56%
Wahed Dow Jones Islamic World ETF
占比0.48%
iShares ESG Advanced MSCI EAFE ETF
占比0.47%
分红派息
近5年累计派现
400.00M
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Mar 01, 2022
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
May 04, 2022
May 05, 2022
May 03, 2022
Feb 24, 2021
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021
May 05, 2021
May 06, 2021
May 04, 2021
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
